BioPlus to Participate in US Medical Device Expo FIME... Showcasing Next-Generation Bio Products

BioPlus participates in FIME. From the left, local buyer, BioPlus Deputy General Manager Park Seongcheol, Manager Jeong Jaewon, Assistant Manager Yoon Hoseong.

[Asia Economy Reporter Jang Hyowon] BioPlus (CEO Jeong Hyungyu) participated in the "Florida International Medical Expo" (FIME), held at the Miami Convention Center in the United States from July 27 to 29, showcasing various next-generation bio products developed by the company.

FIME is the largest medical device exhibition in the Americas, including the United States, Canada, Brazil, and Latin America, attracting over 12,000 medical professionals and industry stakeholders from more than 120 countries worldwide every year.

BioPlus, which is expanding its overseas market share with high quality and technology, increased product awareness at this FIME by exhibiting its main product, fillers, as well as already commercialized adhesion barriers, synovial fluid, and cystitis treatments.

In particular, the company attracted attention from medical professionals and stakeholders by presenting various next-generation bio products such as ▲“Improved Light-Chain Botulinum Toxin,” which introduces peptides that enhance nerve cell aggregation to improve efficacy and half-life while reducing side effects ▲“Improved Obesity/Diabetes Treatment,” developed from biosimilar products into biobetters through protein half-life regulation and GLP-1 manufacturing technology ▲“Bone Graft Composite Material,” containing recombinant human bone morphogenetic protein-2 (rhBMP-2) to promote bone substitution and restoration in alveolar bone defect areas ▲“Improved Sarcopenia Treatment,” which can improve the quality of life for the elderly population by treating age-related muscle loss ▲and various next-generation bio products such as “Bio Breast and Bio Cartilage,” utilizing proprietary HA manufacturing platform technology.

A company representative stated, “Through participating in this FIME, we have established a foothold for entering the Americas market and built strategic networks,” adding, “We will focus on aggressive sales and marketing targeting the Latin American region, continuous brand communication to grow our scale, and expanding entry into new countries.”